Integral Ad Science (IAS) Stock Forecast, Price Target & Predictions
IAS Stock Forecast
Integral Ad Science stock forecast is as follows: an average price target of $14.67 (represents a 40.38% upside from IAS’s last price of $10.45) and a rating consensus of 'Buy', based on 12 wall street analysts offering a 1-year stock forecast.
IAS Price Target
IAS Analyst Ratings
Buy
Integral Ad Science Price Target by Analyst
Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
---|---|---|---|---|---|---|
Nov 13, 2024 | Matt Farrell | Piper Sandler | $16.00 | $10.60 | 50.94% | 53.11% |
Nov 13, 2024 | Brian Pitz | BMO Capital | $15.00 | $10.60 | 41.51% | 43.54% |
Sep 27, 2024 | Matt Farrell | Piper Sandler | $18.00 | $11.00 | 63.64% | 72.25% |
Sep 06, 2024 | Brian Pitz | BMO Capital | $16.00 | $11.48 | 39.37% | 53.11% |
Aug 05, 2024 | Raimo Lenschow | Barclays | $13.00 | $11.33 | 14.74% | 24.40% |
May 24, 2024 | Youssef Squali | Truist Financial | $18.00 | $9.82 | 83.30% | 72.25% |
May 10, 2024 | Andrew Marok | Raymond James | $13.00 | $9.13 | 42.39% | 24.40% |
Apr 29, 2024 | Rob Sanderson | Loop Capital Markets | $15.00 | $9.79 | 53.22% | 43.54% |
Apr 16, 2024 | Matthew Cost | Morgan Stanley | $12.00 | $9.54 | 25.79% | 14.83% |
Jun 14, 2023 | Jason Helfstein | Oppenheimer | $25.00 | $18.88 | 32.42% | 139.23% |
Aug 15, 2022 | Brent Thill | Jefferies | $15.00 | $10.45 | 43.54% | 43.54% |
Aug 08, 2022 | Oppenheimer | $15.00 | $9.02 | 66.30% | 43.54% | |
Jul 26, 2022 | Raymond James | $18.00 | $9.42 | 91.08% | 72.25% | |
May 12, 2022 | BMO Capital | $27.00 | $11.10 | 143.24% | 158.37% |
Integral Ad Science Price Target by Period
1M | 3M | 12M | |
---|---|---|---|
# Anlaysts | - | 3 | 9 |
Avg Price Target | - | $16.33 | $15.11 |
Last Closing Price | $10.45 | $10.45 | $10.45 |
Upside/Downside | -100.00% | 56.27% | 44.59% |
Analyst Ratings Upgrades/Downgrades
Date | Company | Previous Rating | New Rating | Rating Change |
---|---|---|---|---|
Nov 13, 2024 | Jefferies | Buy | Buy | Hold |
Nov 13, 2024 | Piper Sandler | Overweight | Overweight | Hold |
Nov 13, 2024 | BMO Capital | Outperform | Outperform | Hold |
Sep 27, 2024 | Piper Sandler | Overweight | Overweight | Hold |
Sep 06, 2024 | BMO Capital | Outperform | Outperform | Hold |
Aug 05, 2024 | Barclays | Equal-Weight | Equal-Weight | Hold |
Aug 02, 2024 | Raymond James | Outperform | Outperform | Hold |
Jul 23, 2024 | Morgan Stanley | Equal-Weight | Equal-Weight | Hold |
May 10, 2024 | Raymond James | Outperform | Outperform | Hold |
Apr 29, 2024 | Loop Capital Markets | Buy | Initialise | |
Apr 16, 2024 | Morgan Stanley | Overweight | Equal-Weight | Downgrade |
Feb 28, 2024 | Oppenheimer | Outperform | Outperform | Hold |
Feb 28, 2024 | Raymond James | Strong Buy | Outperform | Downgrade |
Feb 28, 2024 | Telsey Advisory | Outperform | Outperform | Hold |
Feb 28, 2024 | Barclays | Overweight | Upgrade | |
Feb 28, 2024 | Needham | Buy | Buy | Hold |
Jun 14, 2023 | Oppenheimer | Outperform | Outperform | Hold |
Jun 14, 2023 | BMO Capital | Outperform | Underperform | Downgrade |
Mar 03, 2023 | Daiwa | Outperform | Outperform | Hold |
Mar 03, 2023 | Morgan Stanley | Overweight | Overweight | Hold |
Mar 03, 2023 | HSBC | Buy | Buy | Hold |
Mar 03, 2023 | Oppenheimer | Buy | Buy | Hold |
Mar 03, 2023 | Raymond James | Outperform | Outperform | Hold |
Aug 15, 2022 | Jefferies | Buy | Buy | Hold |
Aug 08, 2022 | Oppenheimer | Outperform | Outperform | Hold |
Jul 26, 2022 | Raymond James | Strong Buy | Strong Buy | Hold |
May 12, 2022 | BMO Capital | Outperform | Outperform | Hold |
May 12, 2022 | Raymond James | Strong Buy | Strong Buy | Hold |
Integral Ad Science Financial Forecast
Integral Ad Science Revenue Forecast
Quarter
Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | - | - | - | - | - | - | - | - | - | - | - | - | $134.29M | $120.33M | - | $106.09M | $117.44M | $101.34M | $100.33M | $89.24M | $102.47M | $79.01M | $75.08M |
Avg Forecast | $188.78M | $167.27M | $160.72M | $141.59M | $169.01M | $150.06M | $143.43M | $127.22M | $148.96M | $138.06M | $126.28M | $112.12M | $131.27M | $113.25M | $112.41M | $102.92M | $111.33M | $99.86M | $97.60M | $85.17M | $95.07M | $75.46M | $70.72M |
High Forecast | $192.48M | $170.55M | $163.87M | $144.37M | $172.32M | $153.01M | $146.24M | $130.06M | $149.38M | $138.13M | $126.30M | $112.12M | $132.20M | $113.25M | $114.62M | $104.94M | $113.51M | $99.86M | $97.60M | $85.17M | $95.07M | $75.46M | $70.72M |
Low Forecast | $185.61M | $164.46M | $158.02M | $139.21M | $166.17M | $147.54M | $141.02M | $125.42M | $148.58M | $137.99M | $126.27M | $112.12M | $130.68M | $113.24M | $110.52M | $101.19M | $109.46M | $99.86M | $97.60M | $85.17M | $95.07M | $75.46M | $70.72M |
# Analysts | 10 | 7 | 5 | 5 | 8 | 5 | 4 | 11 | 11 | 5 | 6 | 6 | 12 | 9 | 9 | 9 | 5 | 5 | 5 | 5 | 6 | 6 | 6 |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 1.02% | 1.06% | - | 1.03% | 1.05% | 1.01% | 1.03% | 1.05% | 1.08% | 1.05% | 1.06% |
Forecast
Integral Ad Science EBITDA Forecast
Quarter
Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 10 | 7 | 5 | 5 | 8 | 5 | 4 | 11 | 11 | 5 | 6 | 6 | 12 | 9 | 9 | 9 | 5 | 5 | 5 | 5 | 6 | 6 | 6 |
EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | $18.41M | $-22.67M | - | $21.90M | $21.37M | $21.35M | $19.26M | $15.87M | $15.05M | $11.18M | $-18.34M |
Avg Forecast | $30.02M | $26.60M | $25.56M | $22.51M | $26.87M | $23.86M | $22.81M | $20.23M | $23.69M | $21.95M | $20.08M | $17.83M | $20.87M | $18.01M | $17.88M | $16.37M | $17.70M | $16.94M | $16.55M | $32.13M | $16.12M | $12.80M | $-104.53M |
High Forecast | $30.61M | $27.12M | $26.06M | $22.96M | $27.40M | $24.33M | $23.25M | $20.68M | $23.75M | $21.96M | $20.08M | $17.83M | $21.02M | $18.01M | $18.23M | $16.69M | $18.05M | $16.94M | $16.55M | $38.56M | $16.12M | $12.80M | $-83.62M |
Low Forecast | $29.51M | $26.15M | $25.13M | $22.14M | $26.42M | $23.46M | $22.42M | $19.94M | $23.63M | $21.94M | $20.08M | $17.83M | $20.78M | $18.01M | $17.57M | $16.09M | $17.41M | $16.94M | $16.55M | $25.71M | $16.12M | $12.80M | $-125.43M |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 0.88% | -1.26% | - | 1.34% | 1.21% | 1.26% | 1.16% | 0.49% | 0.93% | 0.87% | 0.18% |
Forecast
Integral Ad Science Net Income Forecast
Quarter
Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 10 | 7 | 5 | 5 | 8 | 5 | 4 | 11 | 11 | 5 | 6 | 6 | 12 | 9 | 9 | 9 | 5 | 5 | 5 | 5 | 6 | 6 | 6 |
Net Income | - | - | - | - | - | - | - | - | - | - | - | - | $10.16M | $-13.75M | - | $3.15M | $11.49M | $767.00K | $1.96M | $1.16M | $-4.82M | $-9.78M | $-35.06M |
Avg Forecast | $29.54M | $19.94M | $19.15M | $5.57M | $21.55M | $15.85M | $12.35M | $4.96M | $18.82M | $12.40M | $3.95M | $-2.08M | $6.74M | $117.21K | $3.60M | $1.47M | $1.89M | $-234.00K | $2.57M | $2.35M | $-2.57M | $-9.36M | $-199.86M |
High Forecast | $30.29M | $20.45M | $19.64M | $5.71M | $22.10M | $16.25M | $12.66M | $6.61M | $28.23M | $12.90M | $3.96M | $-2.03M | $20.21M | $120.20K | $3.69M | $1.50M | $1.93M | $-234.00K | $2.57M | $2.82M | $-2.57M | $-9.36M | $-159.89M |
Low Forecast | $28.89M | $19.50M | $18.74M | $5.44M | $21.08M | $15.50M | $12.08M | $3.30M | $13.44M | $11.89M | $3.94M | $-2.13M | $-15.72M | $114.65K | $3.52M | $1.44M | $1.85M | $-234.00K | $2.57M | $1.88M | $-2.57M | $-9.36M | $-239.83M |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 1.51% | -117.30% | - | 2.14% | 6.09% | -3.28% | 0.76% | 0.49% | 1.87% | 1.05% | 0.18% |
Forecast
Integral Ad Science SG&A Forecast
Quarter
Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 10 | 7 | 5 | 5 | 8 | 5 | 4 | 11 | 11 | 5 | 6 | 6 | 12 | 9 | 9 | 9 | 5 | 5 | 5 | 5 | 6 | 6 | 6 |
SG&A | - | - | - | - | - | - | - | - | - | - | - | - | $56.38M | $52.22M | - | $46.98M | $51.90M | $48.34M | $45.32M | $39.83M | $44.98M | $35.66M | $60.31M |
Avg Forecast | $88.72M | $78.61M | $75.53M | $66.54M | $79.43M | $70.53M | $67.41M | $59.79M | $70.01M | $64.89M | $59.35M | $52.69M | $61.69M | $53.22M | $52.83M | $48.37M | $52.32M | $46.76M | $45.71M | $80.65M | $44.52M | $35.34M | $33.12M |
High Forecast | $90.46M | $80.15M | $77.01M | $67.85M | $80.99M | $71.91M | $68.73M | $61.13M | $70.20M | $64.92M | $59.36M | $52.69M | $62.13M | $53.23M | $53.87M | $49.32M | $53.35M | $46.76M | $45.71M | $96.78M | $44.52M | $35.34M | $33.12M |
Low Forecast | $87.23M | $77.29M | $74.26M | $65.43M | $78.10M | $69.34M | $66.28M | $58.94M | $69.83M | $64.85M | $59.34M | $52.69M | $61.42M | $53.22M | $51.94M | $47.56M | $51.44M | $46.76M | $45.71M | $64.52M | $44.52M | $35.34M | $33.12M |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 0.91% | 0.98% | - | 0.97% | 0.99% | 1.03% | 0.99% | 0.49% | 1.01% | 1.01% | 1.82% |
Forecast
Integral Ad Science EPS Forecast
Quarter
Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 10 | 7 | 5 | 5 | 8 | 5 | 4 | 11 | 11 | 5 | 6 | 6 | 12 | 9 | 9 | 9 | 5 | 5 | 5 | 5 | 6 | 6 | 6 |
EPS | - | - | - | - | - | - | - | - | - | - | - | - | $0.06 | $-0.09 | - | $0.02 | $0.07 | - | $0.01 | $0.01 | $-0.03 | $-0.06 | $-0.26 |
Avg Forecast | $0.18 | $0.12 | $0.12 | $0.03 | $0.13 | $0.10 | $0.07 | $0.03 | $0.11 | $0.08 | $0.02 | $-0.01 | $0.04 | - | $0.02 | $0.01 | $0.01 | $-0.00 | $0.02 | $-0.04 | $-0.02 | $-0.06 | $-0.04 |
High Forecast | $0.18 | $0.12 | $0.12 | $0.03 | $0.13 | $0.10 | $0.08 | $0.04 | $0.17 | $0.08 | $0.02 | $-0.01 | $0.12 | - | $0.02 | $0.01 | $0.01 | $-0.00 | $0.02 | $-0.04 | $-0.02 | $-0.06 | $-0.04 |
Low Forecast | $0.18 | $0.12 | $0.11 | $0.03 | $0.13 | $0.09 | $0.07 | $0.02 | $0.08 | $0.07 | $0.02 | $-0.01 | $-0.10 | - | $0.02 | $0.01 | $0.01 | $-0.00 | $0.02 | $-0.04 | $-0.02 | $-0.06 | $-0.04 |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 1.53% | -123.24% | - | 2.25% | 6.12% | -3.43% | 0.64% | -0.24% | 2.02% | 1.05% | 6.93% |
Forecast
Integral Ad Science Peer Comparison by Price Target
Ticker | Company | Last Closing Price | Avg Price Target | Upside/Downside | Avg Rating |
---|---|---|---|---|---|
WPP | WPP | $54.25 | $1.23K | 2167.28% | Buy |
EEX | Emerald | $4.76 | $7.90 | 65.97% | Buy |
CMPR | Cimpress | $78.53 | $120.00 | 52.81% | |
IAS | Integral Ad Science | $10.45 | $14.67 | 40.38% | Buy |
CRTO | Criteo | $42.30 | $55.80 | 31.91% | Buy |
OMC | Omnicom Group | $88.97 | $110.25 | 23.92% | Buy |
DLX | Deluxe | $23.27 | $27.00 | 16.03% | Buy |
IPG | Interpublic Group of Companies | $29.17 | $28.50 | -2.30% | Buy |
CTV | Innovid | $3.06 | $2.50 | -18.30% | Buy |
TZOO | Travelzoo | $21.25 | $12.00 | -43.53% | Buy |